CLINICAL_TRIALS
trial_result
· 2021-12-17
Clinical Trial Update: TRuE AD2 - An Efficacy and Safety Study of Ruxolitinib Cream in Adolescents and Adults With Atopic Dermatitis [Phase 3]
Summary
Phase 3 trial update for ruxolitinib cream in adolescents and adults with atopic dermatitis; study completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Incyte Corporation | Conditions: Atopic Dermatitis | Phase 3 | Status: COMPLETED | Results posted: 2021-12-17